跳至主要内容
临床试验/NCT01816932
NCT01816932已完成不适用

Home or Office Visit for Insertion of Etonogestrel Implant: A Pilot Study

Case Western Reserve University2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2013年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
40
试验地点
2
主要终点
Insertion rates of implantable birth control

研究概览

简要总结

This is a pilot study in which women who desire an etonogestrel implant will be randomized to either a home or office insertion visit. The purpose of this research is to study the interest in, feasibility of, and rates of insertion for implantable birth control (Implanon®/Nexplanon®) when inserted at home visit appointments compared to standard office visit appointments.

The ultimate goal of the study is to reduce barriers to insertion of the etonogestrel implant and increase consistent and correct contraception use by introducing a previously unexplored method of access, the home visit.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Insertion rates of implantable birth control

时间窗: Two weeks post-implant insertion at the follow-up telephone call

Assess rates of insertion of etonogestrel contraceptive implant in women randomly assigned to home visits or standard office visits.

次要结局

  • Interest in home visit option(Within 6-8 weeks of enrollment)
  • Rates of return for postpartum follow-up(Within 6-8 weeks of enrollment)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Suji Uhm

MD/MPH Student

Case Western Reserve University

研究点 (2)

Loading locations...

相似试验